Lifetime Brands, Inc. Reports Fourth Quarter 2017 Financial Results
Mar 15, 2018 11:01 am UTC| Business
GARDEN CITY, N.Y., March 15, 2018 -- Lifetime Brands, Inc. (Nasdaq:LCUT), a leading global provider of branded kitchenware, tableware and other products used in the home, today reported its financial results for the...
Neos Therapeutics Reports Fourth Quarter and Full-Year 2017 Financial Results
Mar 15, 2018 11:01 am UTC| Business
DALLAS and FORT WORTH, Texas, March 15, 2018 -- Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative extended-release (XR) products using...
iAnthus Subsidiary GrowHealthy Begins Delivery in Florida, Signs Orlando Dispensary Lease
Mar 15, 2018 11:01 am UTC| Business
NEW YORK and TORONTO, March 15, 2018 -- iAnthus Capital Holdings, Inc. (“iAnthus” or “the Company”), (CSE:IAN) (OTCQB:ITHUF), which owns, operates, and partners with licensed cannabis operations throughout the United...
Bio-Path Holdings to Present Data at the 2018 AACR Annual Meeting
Mar 15, 2018 11:01 am UTC| Business
HOUSTON, March 15, 2018 -- Bio-Path Holdings, Inc. (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid...
Shenandoah Telecommunications Company Reports Fourth Quarter and Full Year 2017 Results
Mar 15, 2018 11:01 am UTC| Business
EDINBURG, Va., March 15, 2018 -- Shenandoah Telecommunications Company (“Shentel”) (NASDAQ:SHEN) announces financial and operating results for the three months and for the year ended December 31, 2017. Consolidated...
Mar 15, 2018 11:01 am UTC| Business
CARMIEL, Israel, March 15, 2018 -- Protalix BioTherapeutics, Inc. (NYSE American:PLX) (TASE:PLX), a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins...
Mar 15, 2018 11:01 am UTC| Business
RANCHO CORDOVA, Calif., March 15, 2018 -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced that the company will...